Stockreport

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, announced that in connection with Dr. Aggarwal joining Cardiff Onc [Read more]